............................
NEW YORK
Philippe Chambon
Ryan Cochran
William Ho
Ron Hunt
Isaac Manke
James Niedel
Liam Ratcliffe
Craig Slutzkin
MENLO PARK
Mark Charest
Jeani Delagardelle Michael Dybbs
Kathleen LaPorte
+ Vijay Lathi
............................
Advisory Board
............................
 |
Vijay Lathi
..................................
Managing Director
Menlo Park
Vijay Lathi is a Managing Director and concentrates
primarily on our information convergence and diagnostics investments. Vijay
joined Sprout in 1998, and was part of the team that spun out of
Sprout in 2005 to form New Leaf.
Prior to joining Sprout, working as an analyst in the Healthcare
Venture Capital Group at Robertson Stephens & Co. and Cornerstone
Research, a consulting firm focused on financial and economic
analysis for business litigation. Vijay graduated from the
Massachusetts Institute of Technology and Stanford University where
he received his B.S. and M.S. in Chemical Engineering, with an
emphasis on the application of engineering to life science
technology. Vijay is also a member of AiCHE.
"I have found the input from Vijay Lathi,
the New Leaf representative to the Board of Directors, to be
thoughtful and insightful, based on a deep understanding of our area
of business. Their attitude, their advice and their network are all
proving very helpful in accelerating the company's success."
Dr. Peter Wrighton-Smith
CEO, Oxford Immunotec Ltd.
|

Advanced Cell Diagnostics
Aviir
Expression Diagnostics
iRhythm Technologies
Kalypsys
Oxford Immunotec

Awarepoint
Labycte
TigerText

ePocrates (NASDAQ: EPOC, Acquired by athenahealth)
Focus Diagnostics (Acquired by Quest Diagnostics)
Ilypsa (Acquired by Amgen)

(650) 234-2700
|